Madrigal Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Madrigal Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Madrigal Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Madrigal Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $34M | 125k | 267.04 |
2023-12-31 | $20M | 88k | 231.38 |
2023-09-30 | $8.2M | 56k | 146.04 |
2023-06-30 | $5.4M | 23k | 231.00 |
2023-03-31 | $7.5M | 31k | 242.26 |
2022-12-31 | $28M | 97k | 290.25 |
2022-09-30 | $1.7M | 26k | 65.00 |
2022-06-30 | $1.3M | 18k | 71.60 |
2022-03-31 | $2.9M | 30k | 97.79 |
2021-12-31 | $1.9M | 22k | 84.70 |
2021-09-30 | $1.7M | 22k | 79.84 |
2021-06-30 | $592k | 6.1k | 97.33 |
2021-03-31 | $1.9M | 17k | 116.99 |
2020-12-31 | $267k | 2.4k | 110.97 |
2020-09-30 | $304k | 2.6k | 118.76 |
2020-06-30 | $282k | 2.5k | 113.47 |
2020-03-31 | $640k | 9.6k | 66.75 |
2019-12-31 | $100k | 1.1k | 92.92 |
2019-09-30 | $2.1M | 25k | 86.24 |
2019-06-30 | $1.2M | 11k | 104.84 |
2019-03-31 | $1.2M | 9.6k | 125.00 |
2018-12-31 | $669k | 5.9k | 112.76 |
2018-09-30 | $1.6M | 7.6k | 214.15 |
2018-06-30 | $2.5M | 8.8k | 279.63 |
2018-03-31 | $4.5M | 39k | 116.75 |
2017-12-31 | $17k | 187 | 90.91 |
2017-09-30 | $46k | 1.0k | 44.62 |
2017-03-31 | $29k | 1.9k | 15.59 |
2016-12-31 | $14k | 967 | 14.55 |
2016-09-30 | $2.0k | 142 | 14.08 |